Could Flozins Be the Statins for Risk-Based Primary Prevention of Heart Failure?

Priya M. Freaney; Donald M. Lloyd-Jones; Sadiya S. Khan

doi:10.1001/jamacardio.2021.1133

Could Flozins Be the Statins for Risk-Based Primary Prevention of Heart Failure?

Priya M. Freaney, Donald M. Lloyd-Jones, Sadiya S. Khan^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	741-742
Number of pages	2
Journal	JAMA cardiology
Volume	6
Issue number	7
DOIs	https://doi.org/10.1001/jamacardio.2021.1133
State	Published - Jul 2021

Funding

grants from the American Heart Association during the conduct of the study and grants from the National Institutes of Health during the conduct of the study and outside the submitted work. No other disclosures were reported.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2021.1133

Cite this

@article{a6cdaceb1ede4cd1ab73a075a7230ffc,

title = "Could Flozins Be the Statins for Risk-Based Primary Prevention of Heart Failure?",

author = "Freaney, {Priya M.} and Lloyd-Jones, {Donald M.} and Khan, {Sadiya S.}",

note = "Funding Information: grants from the American Heart Association during the conduct of the study and grants from the National Institutes of Health during the conduct of the study and outside the submitted work. No other disclosures were reported.",

year = "2021",

month = jul,

doi = "10.1001/jamacardio.2021.1133",

language = "English (US)",

volume = "6",

pages = "741--742",

journal = "JAMA cardiology",

issn = "2380-6583",